Professor, Psychiatry, University of Pittsburgh School of Medicine
Psychiatry
Dr. Kadiamada N. Chengappa, MD
|
|
Give Review
Kadiamada Chengappa is an expert in the field of Psychiatry. He attended Kasturba Medical College Manipal. Kadiamada Chengappa is a published doctor as well. He has 93 publications published. The latest was: Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. Kadiamada Chengappa accepts Medicare payments and is listed with Medicare.gov.
Publications
- Screening for obstructive sleep apnea among individuals with severe Mental illness at a primary care clinic.
- Recurrent episodes of hypothermia with psychiatric medications: an unsuspected case of primary adrenal insufficiency.
- The off-label use of clozapine in adolescents with bipolar Disorder, intermittent explosive Disorder, or posttraumatic stress Disorder.
- Quetiapine with lithium or divalproex for the treatment of Bipolar mania: a randomized, double-blind, placebo-controlled study.
- Relapse prevention in bipolar I Disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
- Relationship of birth cohort and early age at onset of illness in a bipolar Disorder case registry.
- A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with Schizophrenia.
- A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with Schizophrenia or schizoaffective disor...
- Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for Bipolar mania.
- Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
- The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic Disorders.
- The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric ...
- The evolving role of topiramate among other mood stabilizers in the management of bipolar Disorder.
- Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset Schizophrenia.
- Citalopram as adjunctive therapy in Bipolar depression.
- Efficacy of olanzapine in Combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
- Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital.
- Differentiating primary pathophysiologic from secondary adaptational processes.
- Anxiety Disorders and major depression, together or apart.
- Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidep...
- Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II Disorders in a voluntary registry.
- Topiramate as add-on treatment for patients with Bipolar mania.
- Illness characteristics and their association with prescription patterns for bipolar I Disorder.
- Inositol as an add-on treatment for Bipolar depression.
- Psychotropic drug prescription patterns among patients with bipolar I Disorder.
- Response to placebo among bipolar I Disorder patients experiencing their first manic episode.
- Impact of risperidone on seclusion and restraint at a state psychiatric hospital.
- Side effect profile of enteric-coated divalproex sodium versus valproic acid.
- Use of electroconvulsive therapy in a state hospital: a 10-year review.
- Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
- Cerebrospinal cytokine levels in patients with acute depression.
- Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality Disorder.
- Acute myo-inositol enhances swimming activity in goldfish (short communication).
- Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
- Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.
- Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
- Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatment.
- Gastroesophageal reflux as a possible result of clozapine treatment.
- Second thoughts about clozapine as a treatment for neuroleptic-induced akathisia.
- The effects of clozapine on negative symptoms in patients with Schizophrenia with minimal positive symptoms.
- Obsessive-compulsive symptoms in Schizophrenia: a comparison of olanzapine and placebo.
- The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
- Obstetric complications and autoantibodies in Schizophrenia.
- Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients.
- Further study of neuroleptic malignant syndrome.
- Clozapine, obsessive symptoms, and serotonergic mechanisms.
- Autoimmunity in Schizophrenia: a review of recent findings.
- An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with Schizophrenia.
- Seizures and clozapine dosing schedule.
- The prevalence of akathisia in patients receiving stable doses of clozapine.
- Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of Illness.
- Iron for chronic and persistent akathisia?
- Differences in serum interleukin-6 (IL-6) between healthy dextral and non-dextral subjects.
- Clozapine use in female geriatric patients with psychoses.
- Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype.
- The Marfan''s syndrome: successful surgical palliation for annulo-aortic ectasia.
- Delusions of pregnancy in men.
- Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.
- Handedness and autoantibodies.
- Emergence of obsessive compulsive symptoms during treatment with clozapine.
- Altered interleukin-2 production in Schizophrenia: association between clinical state and autoantibody production.
- The prevalence of autoantibodies among right and left handed schizophrenic patients and Control subjects.
- Non-right sidedness: an association with lower IL-2 production.
- Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies.
- Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
- Elevated IgG anti-histone antibodies in a subgroup of medicated schizophrenic patients.
- Recurrent pancreatitis on clozapine re-challenge.
- Atypical mood stabilizers: a new role for neuroleptics?
- "Does one shoe fit all?".
- Hypomania: hype or mania?
- Editorial. A new initiative, the Bipolar Bulletin.
- Lithium: the long road.
- The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).
- Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
- Identifying and treating cognitive impairment in bipolar Disorder.
- Lithium specificity in bipolar illness: a classic agent for the classic Disorder.
- A preliminary study of sustained-release bupropion for smoking cessation in bipolar Disorder.
- Reporting outcomes in clinical trials for bipolar Disorder: a commentary and suggestions for change.
- The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
- Bipolar Disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.
- Development of procedures for early screening of smoking cessation medications in humans.
- Effects of topiramate on smoking in patients with schizoaffective Disorder, bipolar type.
- Weight gain and metabolic issues of medicines used for bipolar Disorder.
- Exposure to nitrous oxide may be associated with high homocysteine plasma levels and a risk for clinical depression.
- Treatment of Bipolar mania with atypical antipsychotics.
- Obesity and medical Illnesses in psychiatric patients admitted to a long-term psychiatric facility.
- Olanzapine use in subjects with pervasive developmental Disorder displaying aggression and/or self-mutilation.
- Recovery and functional outcomes following olanzapine treatment for Bipolar I mania.
- Leukopenia in clozapine treated patients may be induced by other Drugs: a case series.
- Dosage and administration issues of antipsychotic agents (and adjunctive medicines) in the acute stabilization of psychoses.
- The prevalence of the metabolic syndrome in patients with schizoaffective Disorder--bipolar subtype.
- Anger attacks in Bipolar depression: predictors and response to citalopram added to mood stabilizers.
Procedures Preformed
- Group Psychotherapy
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
Kasturba Medical College Manipal
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1225000730 | |
| NPPES Provider LastName | CHENGAPPA | |
| NPPES Provider FirstName | KADIAMADA | |
| NPPES Provider ZIPCode | 152132593 | |
| NPPES Provider State | PA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 601.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225000730 |
| Last Name Of The Provider | CHENGAPPA |
| First Name Of The Provider | KADIAMADA |
| View All |
Similar Doctors
|
|
Dr. Elizabeth Hepler-Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard J. Aizenstein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul U. Bulgarelli, DO |
|
|
Dr. Jerome M. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia A. Wilkosz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Candace M. Fraser, DO |
|
|
Dr. Marie A. Gebara, MD |
|
|
Dr. Nina L. Yokochi-Funkhouser, DO |